Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Retinal neuroaxonal degeneration in NMOSD vs. MS and unaffected controls: A systematic review and meta-analysis of OCT biomarkers.
Acute Motor Axonal Neuropathy (AMAN) Variant of Guillain-Barré Syndrome Following Influenza Vaccination as the Initial Presentation of Systemic Lupus Erythematosus With Lupus Nephritis.
Atypical Hemorrhagic Stroke Followed by Bilateral Optic Neuritis in MOG Antibody-Associated Disease.
Carboplatin induces optic nerve oligodendrocyte loss and impairs myelin sheath microstructure in a mouse model of neurofibromatosis type 1 (NF1).
Mitochondrial microprotein MOCCI controls neuroinflammation by altering glial activation states.
Effects of Edaravone on Recovery of the Facial Nerve After Crush Injury: Original Study-Brief Clinical.
The Microglial NLRP3 Inflammasome in Multiple Sclerosis: Bridging Innate Immunity, Chronic Inflammation, and IFN-β Response.
Controversies in MS: MS phenotypes should be abandoned in favour of a continuous disease spectrum model - YES.
Prognostic factors in paediatric-onset multiple sclerosis: a narrative review.
Gap junction protein gamma 2 (GJC2) gene frameshift deletion in Toy Poodles with hypomyelinating leukodystrophy resembling human Pelizaeus-Merzbacher-like disease 1.
Measurements and management of multiple sclerosis-related fatigue: an umbrella review and meta-analysis.
Disproportionate pace of evidence-based care implementation in pediatric-onset multiple sclerosis: consequences and opportunities.
[Ureaplasma infections in the immunocompromised patient].
Feasibility of intra-day blood biomarker and ecological momentary assessment collection in multiple sclerosis.
Queer Science and Scientists Are Shaping the Future of Immunology.
Emergency department use before multiple sclerosis: Presenting complaints and discharge diagnoses.
Botulinum toxin type A attenuates trigeminal neuralgia-like pain by suppressing CGRP release and modulating NaV1.7-associated signaling.
Epitope spreading in multiple sclerosis is shaped by the spatial organisation of immune responses.
Physical and mental health-related quality of life outcomes of non-pharmacological interventions in early multiple sclerosis: A systematic review and meta-analysis.
Fifteen-Year Longitudinal Changes in Peripapillary Retinal Nerve Fiber Layer Thickness in Multiple Sclerosis.
Aberrant signals in vascular dementia: Pleiotrophin/laminin pathway and glutamate metabolic dysregulation.
Long-term outcomes of childhood encephalitis in Australia: burden and predictors from the Australian childhood encephalitis (ACE) prospective multicentre cohort.
Persistent SOX10 expression in terminal glial cells of human cutaneous sensory corpuscles throughout life.
Therapeutic Advances and Biomarkers in Multiple Sclerosis.
Hyaluronidase-Facilitated Subcutaneous Immunoglobulin 10% as Maintenance Therapy for Japanese Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy and Multifocal Motor Neuropathy: A Phase 3, Open-label Clinical Trial.

Pages